Risk-directed therapy and research in neuroblastoma
Journal
Journal of the Formosan Medical Association
Journal Volume
113
Journal Issue
12
Pages
887-889
Date Issued
2014
Author(s)
SDGs
Other Subjects
isotretinoin; MYCN protein, human; nuclear protein; oncoprotein; autologous stem cell transplantation; cancer radiotherapy; disease course; follow up; high risk population; human; induction chemotherapy; nerve cell differentiation; neuroblastoma; palliative therapy; Short Survey; Taiwan; adolescent; cancer staging; child; gene amplification; gene dosage; genetics; infant; medical research; neuroblastoma; newborn; pathology; preschool child; prognosis; risk assessment; young adult; Adolescent; Biomedical Research; Child; Child, Preschool; Gene Amplification; Gene Dosage; Humans; Infant; Infant, Newborn; Neoplasm Staging; Neuroblastoma; Nuclear Proteins; Oncogene Proteins; Prognosis; Risk Assessment; Young Adult
Publisher
Elsevier
Type
journal article